Gossamer Bio advances the Feb. 2026 PROSERA Phase 3 readout for seralutinib in PAH, with expanded endpoints and a new ILD trial. Learn why GOSS stock is a hold.

A class 10 student has stopped attending school after allegedly being assaulted by a group of youths demanding extortion money outside a private school in the Ghazipur police station area of Lucknow.

Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, ...

Stacy Zhang never liked science and used to spend classes chatting with friends. Now she is the state’s best biology and ...

Bio-Techne Corp. closed 27.55% short of its 52-week high of $79.28, which the company achieved on February 5th.

The Bailey-Matthews National Shell Museum & Aquarium will host a Marine Biology and Beach Field Lab on Dec. 19 from 7 to 9 ...

A gunman opened fire during a final exam review for the economics class of a Brown University professor, who also teaches Jewish studies courses, in Providence, R.I., on Saturday afternoon, killing ...

Nagpur: The Central Board of Secondary Education (CBSE) has issued a strict advisory ahead of the 2026 Class 10 board ...

Tall rushing and receiving yards and record-breaking quarterbacks were the name of the game this season in the Mid-Penn ...

ChatGPT and its peers have become the bane of teachers. Students churn out homework assignments with it and, according to one ...

Detailed price information for Sab Biotherapeutics Inc (SABS-Q) from The Globe and Mail including charting and trades.

The government has decided to create a 150 billion Korean won clinical phase 3 specialized fund to support the global expansion of K-Bio. Additionally, it plans to develop new export models in the ...